Rodenticidal hepatotoxicity: Raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol
暂无分享,去创建一个
E. Elias | S. Nair | A. Goel | S. Jacob | K. Abhilash | K. A. Balasubramanian | M. Sen | C. Eapen | J. Mammen | K. Subramani | U. Zachariah | C. Eapen | Debasis Sardar | N. Mathews | Anand Sharma | L. Thomas | Ajith Thomas | L. Patel | B. Vijayalekshmi | Shankar Jhanwar
[1] Y. Chawla,et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models , 2017, Hepatology International.
[2] A. Mishra,et al. Clinical spectrum of yellow phosphorous poisoning in a tertiary care centre in South India: a case series , 2017, Tropical doctor.
[3] P. Coppo,et al. Thrombotic thrombocytopenic purpura. , 2017, Blood.
[4] M. Manns,et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. , 2017, Journal of hepatology.
[5] H. Deckmyn,et al. N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. , 2017, Blood.
[6] A. Ramachandran,et al. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure , 2016, Indian Journal of Gastroenterology.
[7] O. V. Sudheer,et al. Acute liver failure due to zinc phosphide containing rodenticide poisoning: Clinical features and prognostic indicators of need for liver transplantation , 2015, Indian Journal of Gastroenterology.
[8] B. Jilma,et al. VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP , 2014, Thrombosis and Haemostasis.
[9] C. Stephens,et al. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. , 2014, Gastroenterology.
[10] R. Porte,et al. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome , 2013, Hepatology.
[11] E. Elias,et al. Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency. , 2013, Journal of hepatology.
[12] S. Khanal,et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure , 2012, Gut.
[13] A. Dirican,et al. Living donor liver transplantation for acute liver failure in pediatric patients caused by the ingestion of fireworks containing yellow phosphorus , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] J. Moake,et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. , 2011, The Journal of clinical investigation.
[15] T. Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001 .
[16] C. Sprung,et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.
[17] J. Moake,et al. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. , 1998, The American journal of the medical sciences.